GlassScriptPhysician profile
Mark Christopher Leu
NPI 1376538744
$1,958.82
in general payments reported to CMS, 2019-2025
19 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $696 · 2022: $403 · 2023: $315 · 2024: $388 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.75 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $481.83 | 2021-2025 | Myrisk, Prolaris |
| Astellas Pharma US INC | $239.97 | 2021-2025 | Xtandi |
| Boston Scientific Corporation | $180.17 | 2021-2025 | Ams 700 Cxr Rte Kit, Ams 700, Bulkamid |
| Medtronic, INC. | $172.30 | 2021-2024 | Interstim |
| Pfizer INC. | $133.71 | 2021-2025 | |
| Antares Pharma, INC. | $121.47 | 2021-2024 | Xyosted |
| Axonics, INC. | $96.08 | 2021-2024 | Axonics |
| Abbvie INC. | $91.54 | 2021-2023 | |
| Myovant Sciences INC. | $82.82 | 2021 | |
| Urovant Sciences INC | $60.46 | 2021-2022 | |
| Teleflex LLC | $60.20 | 2021-2025 | Urolift |
| Urogen Pharma, INC. | $54.04 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $44.76 | 2023 | Gemtesa |
| Janssen Biotech, INC. | $40.53 | 2021-2023 | Erleada |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $17.25 | 2021 | |
| Coloplast Corp | $16.88 | 2022 | |
| Tolmar, INC. | $15.69 | 2024 | |
| Cook Medical LLC | $14.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Leu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.